CEACAM5 and colorectal carcinoma: Therefore, our study aimed to combine CD45neg EpCAMpos CTCs and CD45neg EpCAMneg cells to predict CRC, besides, based on existing conventional serum biomarker CEA, to evaluate add-on combining both CTC molecular biomarkers whether can improve the performance of AUROC for advanced CRC and CRC metastasis prediction.